Bafna Pharmaceuticals Limited (NSE:BAFNAPH)
India · Delayed Price · Currency is INR 127.89
+6.09 (5.00%)
Feb 10, 2026, 3:28 PM IST
Bafna Pharmaceuticals Market Cap
Bafna Pharmaceuticals has a market cap or net worth of 2.88 billion as of February 10, 2026. Its market cap has increased by 45.00% in one year.
Market Cap
2.88B
Enterprise Value
3.20B
Revenue
1.42B
Ranking
n/a
PE Ratio
32.85
Stock Price
127.89
Market Cap Chart
Since March 2, 2020, Bafna Pharmaceuticals's market cap has increased from 10.88M to 2.88B, an increase of 26,378.26%. That is a compound annual growth rate of 155.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 9, 2026 | 2.88B | -19.19% |
| Dec 31, 2025 | 3.57B | 91.03% |
| Dec 31, 2024 | 1.87B | -14.24% |
| Dec 29, 2023 | 2.18B | -8.68% |
| Dec 30, 2022 | 2.38B | -33.96% |
| Dec 31, 2021 | 3.61B | -10.71% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Mar 2, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jagsonpal Pharmaceuticals | 11.25B |
| Ind-Swift Laboratories | 10.79B |
| Sakar Healthcare | 9.73B |
| Sigachi Industries | 9.17B |
| Valiant Laboratories | 3.20B |
| Nectar Lifesciences | 2.61B |
| Brooks Laboratories | 1.79B |
| Alpa Laboratories | 1.49B |